baber/WOPTO huggingface dataset:
Patent NZ-234482-A (NZ)
Title: Removal of isocyanic acid from an ammonia-containing gas
Inventor: MULLNER MARTIN
IPC: C07C273/18
Filed: 1990-07-12
Abstract: In the process, isocyanic acid is isolated from a gaseous mixture of isocyanic acid and ammonia by introducing a tertiary amine or ether at 250 to 600 DEG C. The gaseous reaction mixture is introduced into an inert diluent and cooled, an adduct of isocyanic acid and tertiary amine or ether condensing and the ammonia being separated off as a gas. A subsequent conversion of the adduct gives an unsymmetrically substituted urea, a carbamate, a thiocarbamate or a substituted isocyanate.
Patent NZ-235899-A (NZ)
Title: Anhydrous crystals of 4-carbamoyl-1-beta-d-ribofuranosyl imidazolium-5-olate and method of preparation
Inventor: OZEKI SHINJI
IPC: C07H19/052
Filed: 1990-10-30
Abstract: Anhydrous crystals of 4-carbamoyl-1- beta -D-ribofuranosyl imidazolium-5-oleate are disclosed. The crystals possess (1) water content of 0.5% by weight or less (the Karl Fisher method), and (2) specific IR spectrum absorption peaks in the neighborhoods of 3580, 1852, 1630, 1575, and 1554 cm<-><1>. They are stable against heat and high humidity conditions and can easily be manufactured by using ethanol. The compound has superior immuno-suppressing activity and is thus made into preparations for oral administration.
Patent NZ-237224-A (NZ)
Title: N-cycloalkylalkylamine derivatives and pharmaceutical formulations thereof
Inventor: AUBARD GILBERT
IPC: C07D/
Filed: 1991-02-26
Abstract: N-Cycloalkylalkylamines of general formula (I) <IMAGE>  in which:   R1 is a furyl or thienyl radical or is a phenyl radical, provided that Q denotes a 1,2-cyclopropanediyl group,   R2 is lower alkyl,   R3 is hydrogen or lower alkyl,   m has the value 1 or 2,   R4 is cycloalkyl -CH(CH2)n, in which n is an integer from 2 to 5,   R5 is optionally substituted phenyl or thienyl, Q is 1,2-ethylenediyl or 1,2-cyclopropanediyl, and their addition salts with acids.   These amines are psychotropic medications and are also useful in gastroenterology.
Patent NZ-275410-A (NZ)
Title: Linking element and metallic plate to be fastened to a concrete slab surface of foot that is attached to plate has array of projections
Inventor: KOCH EBERHARD
IPC: B23K11/00
Filed: 1994-10-13
Abstract: A linking element (13) for fastening metallic bodies on or in concrete building elements has an anchoring head (16) that may be anchored in the concrete building element and a foot (15) that may be welded to the metallic body. In order to achieve reliable, highly traction-resistant spot-welding between the linking element and the metallic body, the surface (19) of the foot (15) that faces the metallic body is provided with several projections distributed thereover.
Patent NZ-286092-A (NZ)
Title: Acarbose biosynthesis genes from a strain of actinomycetes
Inventor: CRUEGER ANNELIESE
IPC: C07K14/365
Filed: 1996-02-28
Abstract: DNA (I) with a 2219 bp sequence given in the specification is new. Also claimed are: (1) functional variants of (I); (2) vectors contg. (I) or its variants; (3) microorganisms transformed with the vectors of (2); (3) an amino acid sequence with the above 2219 bp sequence (sic); and (4) proteins contg. at least part of the amino acid sequence of (3).
Patent NZ-307613-A (NZ)
Title: Device for concurrent delivery of measured quantities of at least two liquids
Inventor: WRIGLEY ANDREW NICHOLSON
IPC: G01F11/32
Filed: 1996-05-13
Abstract: A measure (1) for dispensing measured quantities of two liqueurs from a pair of bottles has a pair of measuring receiving bowls (5, 6) associated with the bottles. Sleeves (32, 33) engage within necks of the bottles for delivery of liquid from each bottle to an associated bowl (5, 6). Valve members (28, 29) in each bowl (5, 6) have normally open inlet liquid seals (18, 19) which cooperate with the sleeves (32, 33) to control filling of the bowls (5, 6). Outlet liquid seals (16, 17) on the valve members (28, 29) normally close liquid outlets (21, 22) of the bowls (5, 6). An actuating lever (60) is operable to raise the valve members (28, 29), moving the seals (16, 17, 18, 19) upwardly for opening the outlets (21, 22) and closing inlets (20, 20a) of the bowls (5, 6). Thus, liquid measures flow from the bowls (5, 6) substantially concurrently into a glass or the like placed below the liquid outlets (21, 22). The outlets (21, 22) are arranged to direct the two liquids to opposite sides of the glass so that the liquids remain separated within the glass. Release of the actuating lever (60) drops the valve members (28, 29) closing the liquid outlets (21, 22) and opening the inlets (20, 20a) for recharging the bowls (5, 6).
Patent NZ-323848-A (NZ)
Title: Rolling door drive assembly with remotely operated actuator to engage and disengage pivotal motor and drive assembly
Inventor: LEIVENZON JACK
IPC: E06B9/70
Filed: 1996-12-20
Abstract: A rolling door drive assembly including a final drive unit for connection to a door, whereby the door may be rotated by the final drive unit about an axis to open and close the door, a motor, a drive between the final drive unit and the motor operatively engaged with the motor, one or more drive axes about which one or more components of the drive rotate to transfer drive from the motor to the final drive unit, an actuator to bring the drive to a first configuration at which the motor is engaged to drive the final drive unit through the drive and to bring the drive to a second configuration at which the motor is disengaged from driving the final drive unit, and a resilient spring for urging the drive into one of the configurations. The actuator includes a cam rotatable about a cam axis separate from the one or more drive axes. The cam acts to set the desired configuration of the drive.
Patent NZ-331457-A (NZ)
Title: Methoxybenzophenone compounds, a process for their preparation and a method involving them for combating fungal growth
Inventor: CURTZE JUERGEN
IPC: C07C45/70
Filed: 1998-08-19
Abstract: his invention relates to benzophenone compounds as identified in formula 1, wherein: R1 represents a halogen atom or an alkyl or haloalkyl group; R2 represents a hydrogen or halogen atom, or an alky, haloalkyl, alkoxy or nitro group; or R1 and R2 together represent a group of formula -CH=CH-CH=CH-; R3 and R4 e4ach independently represent an optionally substituted alkyl group; n is an integer from 0 to 3.  This invention also describes a process for their preparation, compositions containing such compounds, a method for combating a fungus at a locus comprising treating the locus with such compounds and their use as fungicides.
Patent NZ-505846-A (NZ)
Title: Novel polymerizable fatty acids, phospholipids and polymerised liposomes therefrom
Inventor: BREY ROBERT N
IPC: C11C3/00
Filed: 1998-12-28
Abstract: An oral drug delivery system which delivers biologically active substances to the mucosal tissue of the intestine utilizing polymerized liposomes. Polymerizable fatty acids having a polymerizable group, a surfactant group, and a functional group, and optionally coupled to ligands which target mucosal tissue in the intestine are disclosed. Negatively charged polymerizable lipids which have phosphatidyl inositol (PI), phosphatidyl glycerol (PG) or phosphatidyl serine (PS) groups on a polymerizable backbone are also described
Patent NZ-506837-A (NZ)
Title: Dredging/excavating through ground layers using water nozzles at 20 and 50 bar respectively behind/through and in front of dredging component
Inventor: VANDYCKE STEFAAN
IPC: E02F3/92
Filed: 1999-02-10
Abstract: An apparatus and method for dredging under water ground layers  includes  the steps of providing a  dredging  device composed  of a mechanical dredging component having  a  part operative  to  contact  the under water  ground  layers  and exert  a  dredging  action;  and  at  least  one  water  jet effective  to inject water under pressure in an  area  where the    mechanical   dredging   component    is    operative; mechanically  impacting the underwater  ground  layers  with the  part to fracture the underwater ground layers and  form fractured material; and injecting water under pressure  from the   at  least  one  water  jet  simultaneously  with   the mechanical  impacting  to remove the fractured  material  so that  an improved break-away pattern of material is obtained and reduced wearing of said part.
Patent NZ-508099-A (NZ)
Title: Refrigeration system with independent compartment temperature control
Inventor: BESSLER WARREN FRANK
IPC: F25D29/00
Filed: 2000-11-10
Abstract: A refrigeration system (10) with an outer cabinet (11) having a freezer compartment (12) and a fresh food compartment (14) connected via an opening (34). A compressor (18), condenser (20), expansion device (22) and an evaporator (24) connected in series expand and condense a refrigerant to cool said freezer and fresh food compartment, a discreet speed freezer compartment fan (32) adjacent to the freezer evaporator (24) directs cooled air throughout freezer compartment and through (34) to the fresh food compartment, and a controller (25) coupled to the compressor (18) and the fan (32) in order to generate control signals to regulate the speed of the fan, where the fan operates at high speed if both (12, 14) or fresh food compartment (14) needs cooling and at low speed if only freezer (12) compartment needs cooling.
Patent NZ-510972-A (NZ)
Title: Loudspeakers comprising coupling of phase uncorrelated diffuse sound source to a waveguide
Inventor: HARRIS NEIL
IPC: H04R1/30
Filed: 1999-11-04
Abstract: Using a vibration-exciter transducer (3), the phase uncorrelated diffuse sound source is coupled to a duct or waveguide to direct acoustic energy away from the source. The coupling is achieved through a bending wave mode acoustic radiator panel (2). The waveguide is characterised by having a substantial parallel section (6) that extends beyond the vicinity of the sound source and also by a remote termination (10) of the waveguide or duct.
Patent NZ-513203-A (NZ)
Title: Pyrrolo [2,1-c][1,2,4] benzothiadiazine compounds and pharmaceutical use as AMPA modulators
Inventor: CORDI ALEX
IPC: A61K31/542
Filed: 2001-07-27
Abstract: Described are compounds of formula (I); wherein: R1 represents a hydroxy, RCO-O or RCO-NRa; R2 represents hydrogen, halogen, hydroxy, R'CO-O or R'CO-NR'a; R and R' represent a linear or branched C1-6 alkyl optionally substituted by an aryl group, a linear or branched C2-6 alkenyl group optionally substituted by an aryl group, a linear or branched C1-6 perhaloalkyl group, a C3-7 cycloalkyl group, an adamantyl group, an aryl group or a heteroaryl group; Ra and R'a represent hydrogen or a linear or branched C1-6 alkyl group, a linear or branched C1-6 perhaloalkyl group, a linear or branched C1-6 acyl group, an aryl group or a heteroaryl group. The compounds may be used in medicaments as AMPA modulators.
Patent NZ-521742-A (NZ)
Title: Medication dispenser
Inventor: STEVENS GERARD THOMAS
IPC: B65B5/10
Filed: 2001-06-01
Abstract: A medication tablet dispenser (20) has an upright casing (24) providing a tower which is subdivided by horizontal partitions (25) into eight compartments which individually contain removable holders (28) each containing a charge of tablets to be dispensed.  The holders (28) have framing portions (74) which together provide a funnel (52) opening downwardly into a cavity of a blister sheet.  The casing (24) is vibrated back and forth about its vertical axis through a small angle to cause tablets in the holders to progress towards an outlet leading into the funnel (52) and having an associated ejectors which discharges selected tablets into the funnel, when required by a computer programme.  Conical vibration of the casing (24) is prevented by a connection (32) located on its vertical axis and held stationary by a fixed arm (31).  The ejectors operate in response to slide-rods (40) individually reciprocated by associated solenoids (45) controlled by the computer programme.
Patent NZ-521994-A (NZ)
Title: Compositions and methods for the modulated release of one or more proteins or peptides in a biological environment
Inventor: SHIH CHUNG
IPC: A61K38/095
Filed: 2001-04-06
Abstract: Described are compositions and methods for the modulated release of one or more proteins or peptides.  The composition is comprised of a biocompatible polymeric matrix, a protein and/or peptide, and a sparingly water-soluble or essentially insoluble particle.  The protein is deposited by adsorption or some other mechanism onto the sparingly water-soluble biocompatible particle wherein the protein-particle combination is dispersed within the polymeric matrix.  The deposition of the protein onto the particle acts to modulate the release of the protein or peptide from dosage forms including long-acting dosage systems. As shown in the figure, hGH release from the gel was significantly suppressed when hGH was deposited on zinc carbonate particles. The square symbol represents In vitro dissolution (37oC) of hGH from ReGel(R) (20% w/w polymer in water) without ZnCO3 into 10 mM Hepes buffer (pH 7.4) containing 0.02% TWEEN-80. The triangle symbol represents hGH deposited on zinc carbonate and suspended in ReGel(R) (20% w/w polymer in water) into 10mM HEPES buffer (pH 7.4) containing 0.02% TWEEN-80.
Patent NZ-525978-A (NZ)
Title: A container for separately storing flowable materials but allowing mixing of materials when required
Inventor: HAWTHORNE DONN BEDE
IPC: B65D81/32
Filed: 1998-06-09
Abstract: A container is disclosed for separately containing a first flowable material and a second flowable material until the mixing of the first and the second flowable materials are desired. The first chamber contains the first flowable material and having a first head space comprising a gas at a pressure greater than or equal to atmosphere pressure. A second chamber containing the second gas containing flowable material comprises a second head space comprising a gas at a pressure greater than atmospheric pressure. Further means are disclosed for opening the first chamber to an environment external to the chamber for reducing pressure in the first chamber. The second flowable material is transferred into the first chamber for mixing with the first flowable material when the pressure in the first chamber is reduced by means of a transferring means comprising a conduit extending upwardly form a lower opening immersed in the second flowable material below the second head space, to an upper opening immersed in the first flowable material. The conduit is capable of containing an airlock releasable on the reduction of pressure in the first chamber to allow transfer of the second flowable material along the conduit means to mix with the first flowable material. (62) Divided out of 515671
Patent NZ-526069-A (NZ)
Title: Treatment of statin side effects
Inventor: LINNANE ANTHONY WILLIAM
IPC: A61K31/505
Filed: 2001-11-29
Abstract: Disclosed are combinations of uridine and biological precursors of uridine and compounds of formula (I) wherein R1 is selected from H or alkyl; R2 and R3 are each independently selected from H, OH, alkyl, alkoxy, alkenyl, alkenoxy or alkynoxy; and R4 is alkyl, alkenyl, alkoxy, alkenoxy, alkylol or alkenylol. A preferred compound of formula (I) is Coenzyme Q10. Combinations as described above are useful in the treatment of the side effects of statin therapy, in particular muscle pain. Also disclosed is the use of said combinations for the treatment of muscle pain or fatigue not related to the use of statins.
Patent NZ-529254-A (NZ)
Title: Determination of pregnancy status in an ungulate animal
Inventor: OTT TROY L
IPC: C12Q1/6876
Filed: 2002-06-10
Abstract: Described is a method for determining the pregnancy status in an ungulate animal that comprises determining the level of expression of a pregnancy-induced protein, Type 1 Interferon-induced protein in a body fluid that is collected from the animal during the period of early pregnancy that followed from breeding the animal. The Type 1 Interferon-induced protein expression is also compared to that of non-pregnant animals of the same species. Also described are kits that can be used to determine the pregnancy status of an ungulate animal that comprise containers to hold a test sample, reagents and instructions.
Patent NZ-530028-A (NZ)
Title: Process for producing eplerenone crystalline form exhibiting enhanced dissolution rate
Inventor: BARTON KATHLEEN
IPC: A61P1/16
Filed: 2000-12-04
Abstract: Disclosed is a process for preparing crystalline eplerenone, the process comprising a step of providing a solution of eplerenone starting material in a high boiling point solvent or mixture of solvents comprising a high boiling point solvent, and a step of directly crystallizing from the solution a crystalline form of eplerenone having an orthorhombic crystal system and an X-ray powder diffraction pattern with a peak at 12.0 +/- 0.2 degrees 2theta, wherein the crystallizing step is conducted at a temperature above the enantiotropic transition temperature for the crystalline form. Also disclosed is a process for preparing crystalline eplerenone, the process comprising (a) a step of digesting a low purity eplerenone starting material in a solvent capable of forming a solvated crystalline form of eplerenone or in a mixture comprising such a solvent; (b) a step of crystallizing eplerenone from the solvent or mixture to form a solvate; and (c) a step of desolvating the solvate to provide a crystalline form of eplerenone having an orthorhombic crystal system and an X-ray powder diffraction pattern with a peak at 12.0 +/- 0.2 degrees 2theta.
Patent NZ-530129-A (NZ)
Title: Porous sponge-like cellulosic material containing trace elements for skin wound treatment
Inventor: VILJANTO JOUKO
IPC: A61L15/44
Filed: 2002-06-11
Abstract: A porous sponge-like cellulosic material to be used in treatment of injuries and/or burns comprises at least one element selected from zinc, copper, selenium and iron bound to and/or absorbed into the material matrix in amounts sufficient to support wound base granulation and revascularisation. The amount of each element is ate least 0.1ug/g dry material. A semi-permeable film through which water vapour can permate but which detains proteins with molecular weight > 5000 in the material can be attached on one side of the cellulosic material.
Patent NZ-531584-A (NZ)
Title: Label, typically for wine bottle, with removable central portion
Inventor: MILLER PAUL ANTHONY
IPC: B65D25/20
Filed: 2002-09-05
Abstract: A label 10 is disclosed for affixing to a container of produce 12, the label 10 comprising a front portion 10 for carrying labelling indicia, and an adhesive backing the front portion including a token 14 for identifying the produce, the token 14 being readily severable from the front portion 10 (via a closed line of perforations defining the token perimeter within the label) when the label is affixed to the container 12. A portion of the backing sheet is removable from the adhesive backing sheet such that on severing the token this portion does not extend beyond the perforations of the token perimeter.
Patent NZ-534022-A (NZ)
Title: Sample testing device
Inventor: SALVO LAWRENCE
IPC: B01L3/00
Filed: 2003-01-14
Abstract: A sample testing device that has a buffer container 10 for holding buffer fluid, a filter 30 with a securement for holding a test strip 40, a sample collector 20, and a test strip container 50 that accommodates the filter is disclosed. When the filter is held in the container the test strip is located in the containerÆs receptacle. The sample collector 20 receives the buffer container 10, and the sample collector has a piercing member 23 which, when the buffer container is placed in the sample collector, pierces the buffer container. Buffer fluid in the buffer container then contacts the sample. As buffer fluid flows through the sample collector, the buffer fluid that has contacted the sample passes through the filter to the test strip.
Patent NZ-538584-A (NZ)
Title: Stable liquid composition of oxazaphosphorine, mesna and etherified beta-cyclodextrin
Inventor: DAFTARY GAUTAM VINOD
IPC: A61K31/185
Filed: 2003-09-04
Abstract: A low toxicity, stable oxazaphosphorine containing compositions with mesna for parenteral administration has been described. The process for preparing these compositions essentially requires addition of an oxazaphosphorine antineoplastic to the aqueous solution of an etherified beta-cyclodextrin followed by addition of mesna as such or as an aqueous solution containing optionally, an etherified beta-cyclodextrin. Preferably, the oxazaphosphorine antineoplastic is ifosfamide and the etherified beta-cyclodextrin is 2-hydroxypropyl-beta-cyclodextrin.
Patent NZ-542011-A (NZ)
Title: Nucleotide lipid ester derivatives
Inventor: HECKL-OSTREICHER BRIGITTE
IPC: C07H19/20
Filed: 2004-03-18
Abstract: Disclosed are specific lipidesters of halogenated-adenine nucleotides of formula (I) and their use in the treatment of tumours.
Patent NZ-548896-A (NZ)
Title: 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
Inventor: FANCELLI DANIELE
IPC: C07D495/04
Filed: 2005-02-02
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification, and processes for its preparation. The compounds are protein kinase inhibitors, particularly Aurora Kinases useful in the treatment of cell proliferative disorders.
Patent NZ-552507-A (NZ)
Title: A device for mechanical guiding, a lock module and a lock device comprising such a device
Inventor: COLLIN KJELL
IPC: E05B/
Filed: 2005-06-22
Abstract: A device for mechanically guiding components in a lock arrangement, preferably for guiding a follower unit, comprising an electrically actuable manoeuvring element, which in a preferred form is a motor, is disclosed. A first engagement element is coupled mechanically to the manoeuvring element for linear movement along a movement axis between a first and a second end position. A first arm which is rotatable about a shaft (A) includes a second engagement element located in mechanical engagement with the first engagement element. As each of the first and second engagement elements include a groove which extends at least partially out of parallel with the movement axis of the first engagement element, the first arm is caused to rotate when the first engagement element moves linearly.
Patent NZ-554418-A (NZ)
Title: Surface polymerisation procesess and polymer product using Reversible Addition-Fragmentation chain Transfer (RAFT) agent
Inventor: HAWKETT BRIAN STANLEY
IPC: C08F2/18
Filed: 2005-10-04
Abstract: A method of polymerising monomer to form polymer at the surface of particulate material, said method comprising: providing a dispersion of said particulate material in a continuous liquid phase, said dispersion comprising a RAFT agent as a stabiliser for said particulate material, and said continuous liquid phase comprising one or more ethylenically unsaturated monomers; and polymerising said one or more ethylenically unsaturated monomers under the control of said RAFT agent to thereby form polymer at the surface of said particulate material.
Patent NZ-555533-A (NZ)
Title: Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
Inventor: LEVY ODILE ESTHER
IPC: A61K38/17
Filed: 2005-12-12
Abstract: Provided is a PPF polypeptide comprising specified sequences with an N-terminal fragment comprising the first 17 amino acid residues of native human Peptide YY (hPYY) and a C-terminal fragment comprising amino acid residues 18-36 of native human neuropeptide Y (hNPY), wherein the N-terminal and C-terminal fragments are covalently linked, wherein no more than two amino acid residues at the N-terminus of the PYY fragment may be deleted or absent, and wherein no more than nine amino acid substitutions may be made in each of the N-terminal and C-terminal fragments. The peptides are useful as medicaments for body weight control and lowering plasma triglyceride levels.